Results 81 to 90 of about 36,088 (121)

The Role of Natural Chalcones and Their Derivatives in Targeting Prostate Cancer: Recent Updates. [PDF]

Int J Mol Sci
Hussein OJ, Elkhalifa D, Hassan AF, Alali F, Al Moustafa AE, Khalil A.   +5 more
europepmc   +1 more source

Targeting KIF20A: a new frontier in cancer treatment revealed by multi-omics analysis. [PDF]

Front Immunol
Zhang J, Li G, Qi C, Yang M, Guo W.
europepmc   +1 more source

The histone deacetylase inhibitor CG-745 enhances the radiosensitivity of prostate cancer cells. [PDF]

J Int Med Res
Wu B, Liao SG.
europepmc   +1 more source

SCARNA20 influences the occurrence and development of lung cancer by inhibiting tumor cell proliferation, migration, and invasion. [PDF]

J Thorac Dis
Li Y, Zhang J, Chen Q, Yang H, Xu P, Zhao Y, Li D, Ma Q, Liu D, Liang C.   +9 more
europepmc   +1 more source

MYC at the tumor-immune interface: mechanisms of immune escape and immunotherapy resistance. [PDF]

Front Immunol
González-Larreategui Í, Valdés-Bango Martín M, Casacuberta-Serra S, Soucek L.   +3 more
europepmc   +1 more source

Overcoming acquired doxorubicin resistance of ovarian carcinoma cells by verapamil‑mediated promotion of DNA damage‑driven cytotoxicity. [PDF]

Int J Oncol
Mukinovic E, Federmann S, Messling L, Sekeres M, Mann J, Abbey L, Kassack MU, Fritz G.   +7 more
europepmc   +1 more source

Oleanolic acid and its derivatives in breast cancer therapy: mechanistic insights, structural modifications, and novel delivery strategies. [PDF]

Front Pharmacol
Hu X, Qin Y.
europepmc   +1 more source

Comparative phenotypic and molecular profiling of replicative and chemically-induced senescence in articular chondrocytes. [PDF]

Cell Death Discov
Arteaga MB, Tarasova K, Kidtiwong A, Gültekin S, Gerner I, Jenner F.   +5 more
europepmc   +1 more source

Probabilistic modeling of cell cycle dynamics in response to cell cycle targeting chemotherapy drugs to guide treatment strategies. [PDF]

PLoS Comput Biol
Ma C, Gurkan-Cavusoglu E.
europepmc   +1 more source